ConductScience.org, home

Gene · 2549

NIH grants1,656

NIH grants whose papers are about the gene, through NIH's grant-paper links.

GrantTitleGAB1 papersNewest fiscal year
ZIABC010441Biomolecular Recognition and Binding Mechanisms22025
ZIABC010806Developing Novel Therapies for High Risk Pediatric Cancers22025
ZIABC010999Targeting FGFR4, RAS, and PAX3-FOXO1 gene in Rhabdomyosarcoma22025
ZIADC000039Identification of Genes Causing Syndromic and Nonsyndromic Hearing Impairment22025
ZIADC000088Cellular and Molecular Pathways for Hearing Restoration in the Adult Inner Ear22025
ZIAHD001607Protein Trafficking In The Endosomal-Lysosomal System22025
I01BX000152Regulation of Intestinal Bile Acid Absorption in Health and Cholesterol-Related Disorders12025
I01BX003362Genetics of Cardiometabolic Diseases in the VA Population12025
I01CX001025Investigation of Heart and Vascular Outcomes in Older Veterans12025
IK6BX004603BLRD Research Career Scientist Award Application12025
K08CA256170Rewiring of epigenetic DNA damage response pathways in HPV-induced cancer12025
K12CA086913Paul Calabresi Award in Clinical Oncology Research12025
K12CA090354Training Program in Nervous System Tumors12025
K12GM102779Bronx-Einstein Training in Teaching and Research (BETTR), an IRACDA program12025
KL2TR002015I: Penn State Institutional Career Development Core12025
P01CA097132Sphingolipids in Cancer Biology and Therapy12025
P01CA108671Myeloproliferative Neoplasms-Research Consortium12025
P01CA163222Targetable epigenetic and transcriptional mechanisms in melanoma thatshape the microenvironment12025
P01CA196569Statistical Methods for Integrative Genomics in Cancer12025
P01CA217959Discovering and Exploiting Mechanisms of Neuroblastoma Therapy Resistance12025

Source NIH's project filesgene-search-2026-11-11-0.2.0

Sources 12

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
  • GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
  • HGNCCC0
  • NCBI GenePublic domain (US government)
  • NIH's project files and grant-paper linksPublic domain
  • Open TargetsCC0 1.0
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
  • GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
  • HGNCCC0: https://www.genenames.org/about/license/
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/genes/v1/2549/grants?page=4